Cargando…

Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study

BACKGROUND AND AIMS: Magnesium sulfate (MgSO(4)) treatment is widely used for the prevention of eclamptic seizures. However, its effect on mediators of endothelial dysfunction (ED) and electrolytes remains unclear. We evaluated the effects of MgSO(4) treatment on mediators of ED and electrolytes. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Fondjo, Linda A., Sarpong, Davis, Owiredu, William K. B. A., Opoku, Stephen, Adu‐Bonsaffoh, Kwame, Teviu, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130740/
https://www.ncbi.nlm.nih.gov/pubmed/37123551
http://dx.doi.org/10.1002/hsr2.1232
_version_ 1785031024196976640
author Fondjo, Linda A.
Sarpong, Davis
Owiredu, William K. B. A.
Opoku, Stephen
Adu‐Bonsaffoh, Kwame
Teviu, Emmanuel
author_facet Fondjo, Linda A.
Sarpong, Davis
Owiredu, William K. B. A.
Opoku, Stephen
Adu‐Bonsaffoh, Kwame
Teviu, Emmanuel
author_sort Fondjo, Linda A.
collection PubMed
description BACKGROUND AND AIMS: Magnesium sulfate (MgSO(4)) treatment is widely used for the prevention of eclamptic seizures. However, its effect on mediators of endothelial dysfunction (ED) and electrolytes remains unclear. We evaluated the effects of MgSO(4) treatment on mediators of ED and electrolytes. METHODS: We recruited 100 women comprising 50 severe, 50 mild preeclampsia (PE) as cases and 50 normotensive pregnant women as controls from the Sampa Government Hospital, Ghana. We estimated for adrenomedullin (AM), calcitonin gene‐related peptide (CGRP), soluble forms of intercellular adhesion molecule‐1 (sICAM‐1), Na(+), K(+), and Mg(2+) before MgSO(4) treatment, 24 h after MgSO(4) treatment, and 48 h after delivery. p < 0.05 were considered significant for statistical analyses. RESULTS: Levels of AM, sICAM‐1, and Na(+) decreased significantly at 24 h after MgSO(4) treatment and 48 h after delivery among PE women compared to the AM levels before treatment (p < 0.0001). The levels of CGRP and Mg(2+) increased significantly after 24 h of MgSO(4) treatment and 48 h after delivery among PE compared to the AM levels before treatment (p < 0.0001). The changes in AM, sICAM‐1, CGRP, and Mg(2+) at 24 h after treatment and 48 h after delivery were significantly higher in severe compared to mild PE (p < 0.0001). AM levels reduced significantly by 14.7% in mild and 42.7% in severe PE after MgSO₄ treatment (p < 0.05). sICAM‐1 levels reduced significantly by 20.9% in mild and 25% in severe PE after MgSO₄ treatment. After MgSO₄ treatment, there was significant increase of 42.1% and >100% in CGRP levels in mild and severe PE, respectively (p < 0.05). After MgSO₄ treatment, Mg²⁺ levels increased significantly by 67.0% and 63.8% in mild and severe PE, respectively (p < 0.05). CONCLUSION: MgSO₄ treatment reduces AM, sICAM‐1, and sodium levels but improves magnesium and CGRP in severe than mild PE thus have more beneficial role in severe PE.
format Online
Article
Text
id pubmed-10130740
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101307402023-04-27 Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study Fondjo, Linda A. Sarpong, Davis Owiredu, William K. B. A. Opoku, Stephen Adu‐Bonsaffoh, Kwame Teviu, Emmanuel Health Sci Rep Original Research BACKGROUND AND AIMS: Magnesium sulfate (MgSO(4)) treatment is widely used for the prevention of eclamptic seizures. However, its effect on mediators of endothelial dysfunction (ED) and electrolytes remains unclear. We evaluated the effects of MgSO(4) treatment on mediators of ED and electrolytes. METHODS: We recruited 100 women comprising 50 severe, 50 mild preeclampsia (PE) as cases and 50 normotensive pregnant women as controls from the Sampa Government Hospital, Ghana. We estimated for adrenomedullin (AM), calcitonin gene‐related peptide (CGRP), soluble forms of intercellular adhesion molecule‐1 (sICAM‐1), Na(+), K(+), and Mg(2+) before MgSO(4) treatment, 24 h after MgSO(4) treatment, and 48 h after delivery. p < 0.05 were considered significant for statistical analyses. RESULTS: Levels of AM, sICAM‐1, and Na(+) decreased significantly at 24 h after MgSO(4) treatment and 48 h after delivery among PE women compared to the AM levels before treatment (p < 0.0001). The levels of CGRP and Mg(2+) increased significantly after 24 h of MgSO(4) treatment and 48 h after delivery among PE compared to the AM levels before treatment (p < 0.0001). The changes in AM, sICAM‐1, CGRP, and Mg(2+) at 24 h after treatment and 48 h after delivery were significantly higher in severe compared to mild PE (p < 0.0001). AM levels reduced significantly by 14.7% in mild and 42.7% in severe PE after MgSO₄ treatment (p < 0.05). sICAM‐1 levels reduced significantly by 20.9% in mild and 25% in severe PE after MgSO₄ treatment. After MgSO₄ treatment, there was significant increase of 42.1% and >100% in CGRP levels in mild and severe PE, respectively (p < 0.05). After MgSO₄ treatment, Mg²⁺ levels increased significantly by 67.0% and 63.8% in mild and severe PE, respectively (p < 0.05). CONCLUSION: MgSO₄ treatment reduces AM, sICAM‐1, and sodium levels but improves magnesium and CGRP in severe than mild PE thus have more beneficial role in severe PE. John Wiley and Sons Inc. 2023-04-26 /pmc/articles/PMC10130740/ /pubmed/37123551 http://dx.doi.org/10.1002/hsr2.1232 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Fondjo, Linda A.
Sarpong, Davis
Owiredu, William K. B. A.
Opoku, Stephen
Adu‐Bonsaffoh, Kwame
Teviu, Emmanuel
Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study
title Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study
title_full Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study
title_fullStr Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study
title_full_unstemmed Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study
title_short Effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: A case‐control study
title_sort effect of magnesium sulfate treatment on mediators of endothelial dysfunction and electrolytes in mild and severe preeclampsia: a case‐control study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130740/
https://www.ncbi.nlm.nih.gov/pubmed/37123551
http://dx.doi.org/10.1002/hsr2.1232
work_keys_str_mv AT fondjolindaa effectofmagnesiumsulfatetreatmentonmediatorsofendothelialdysfunctionandelectrolytesinmildandseverepreeclampsiaacasecontrolstudy
AT sarpongdavis effectofmagnesiumsulfatetreatmentonmediatorsofendothelialdysfunctionandelectrolytesinmildandseverepreeclampsiaacasecontrolstudy
AT owireduwilliamkba effectofmagnesiumsulfatetreatmentonmediatorsofendothelialdysfunctionandelectrolytesinmildandseverepreeclampsiaacasecontrolstudy
AT opokustephen effectofmagnesiumsulfatetreatmentonmediatorsofendothelialdysfunctionandelectrolytesinmildandseverepreeclampsiaacasecontrolstudy
AT adubonsaffohkwame effectofmagnesiumsulfatetreatmentonmediatorsofendothelialdysfunctionandelectrolytesinmildandseverepreeclampsiaacasecontrolstudy
AT teviuemmanuel effectofmagnesiumsulfatetreatmentonmediatorsofendothelialdysfunctionandelectrolytesinmildandseverepreeclampsiaacasecontrolstudy